Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOR study: ipragliflozin vs high-dose metformin add-on in type 2 diabetes
jRCTs011180024Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in type 2 diabetes mellitus (T2DM) comparing High-dose metformin with Ipragliflozin add-on to metformin (2 arms). Primary endpoint: Change in HbA1c from baseline to 52 weeks. Started Apr 2015; status: completed.
02
Drugs
ipragliflozinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs011180024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180024.